DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/2s6vjm/endstage_kidney) has announced the addition of the "End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015" report to their offering.
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the End-Stage Kidney Disease.
A key objective of The report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under End-Stage Kidney Disease (End-Stage Renal Disease or ESRD).
- A snapshot of the global Market therapeutics scenario for End-Stage Kidney Disease.
- A review of the marketed products under prescription for End-Stage Kidney Disease, regulatory information and marketing status.
- Coverage of global patent coverage and detailed commentaries on the US patent challenges.
Key Topics Covered:
- Marketed Drugs
- Marketed Details of Drugs by Application Type
- Marketed Details of Drugs (NDA) by Marketing Status
- Marketed Details of Drugs by Patent Expiration Timeline
- Active Pharmaceutical Ingredient (API) Manufacturers Assessment
- API Manufacturers by United States Drug Master File (US DMF) Status
API Manufacturers by US DMF Status
- API Manufacturers in Europe by Country
- API Manufacturers in India by State
- API Manufacturers in China by Province
- Marketed Details of Approved Drugs by Geography
- Active Pharmaceutical Ingredient Manufacturers Assessment for Phase III Pipeline Drugs
- API Manufacturers by US DMF Status (Drug Specific)
- Drugs Market Data and Forecasted Sales Figure (2012-2016)
Marketed Drugs for End-Stage Kidney Disease
- Drug Name
- Drug Description
- Global Active Pharmaceutical Manufacturers for Drug
- Approval Status of Drug
- Patent and Exclusivity Details for Drug
- Company Profile and Financials
Phase III Drugs
- United States Drug Master File (DMF)
For more information visit http://www.researchandmarkets.com/research/2s6vjm/endstage_kidney